Despite there being no differences in functional or structural connectivity comparing controls and preHD participants, we identified a significant positive correlation, predominantly in posterior regions, between functional connectivity and disease burden as measured by CSF NfL, a fluid biomarker of axonal degeneration, detectable in those many years from Huntington’s disease clinical diagnosis. This evidence concerns the gene NEFL and Huntington disease.